Cochleamycin A
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Category | Antibiotics |
Catalog number | BBF-00379 |
CAS | |
Molecular Weight | 374.43 |
Molecular Formula | C21H26O6 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is produced by the strain of Streptomyces sp. DT136. Cochleamycin A showed strong inhibitory activity against tumor cells, with IC50 (μg/mL) of P388, HL60, K562, COL0205 and HT29 cells of 1.6, 14.0, 6.2, 16.5 and 19.1, respectively. It also has anti-gram-positive bacteria activity.
- Specification
- Properties
- Reference Reading
- Price Product List
IUPAC Name | [(1Z,3R,4S,6R,7R,8R,11R,13S,15R)-13-hydroxy-6-methyl-17,18-dioxo-16-oxatetracyclo[13.2.2.03,11.04,8]nonadeca-1,9-dien-7-yl] acetate |
Canonical SMILES | CC1CC2C(C1OC(=O)C)C=CC3C2C=C4C(=O)CC(CC(C3)O)OC4=O |
InChI | InChI=1S/C21H26O6/c1-10-5-17-15(20(10)26-11(2)22)4-3-12-6-13(23)7-14-8-19(24)18(9-16(12)17)21(25)27-14/h3-4,9-10,12-17,20,23H,5-8H2,1-2H3/b18-9-/t10-,12+,13+,14-,15-,16-,17-,20-/m1/s1 |
InChI Key | NQXQKOWVFXXLJS-MMCQDFOUSA-N |
Appearance | Colorless Powder |
Antibiotic Activity Spectrum | Gram-positive bacteria; neoplastics (Tumor) |
BBF-03753 | Baicalin | Inquiry |
BBF-03884 | Formononetin | Inquiry |
BBF-02594 | Pyrrolnitrin | Inquiry |
BBF-03774 | Cephalosporin C Zinc Salt | Inquiry |
BBF-03516 | (±)-Naringenin | Inquiry |
BBF-00968 | Homoalanosine | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
